This is an erratum to: Natalia Filippova, Jeffrey M Grimes, Jianmei W Leavenworth, David Namkoong, Xiuhua Yang, Peter H King, Michael Crowley, David K Crossman, L Burt Nabors, Targeting the TREM1-positive myeloid microenvironment in glioblastoma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac149, https://doi.org/10.1093/noajnl/vdac149
In the originally published version of this manuscript, the Key Points given were incorrect. The correct Key Points for this article are:
TREM1+-microenvironment is a hallmark of glioblastoma and tumor/myeloid-derived cell fusion.
TREM1 is associated with infiltration of Mϕ and PMN cells in the peri-necrotic hypoxic zones.
HuR dimerization inhibitor suppresses the TREM1+-microenvironment and tumor/host cell fusion.
This has been corrected online, and the publisher apologises for the original error.